DenialHelpUnderstand your lupus & rheumatology denial. Build a reviewable appeal.
Upload the denial notice, verify the extracted facts, identify missing evidence, and prepare a package for treating-clinician review. The notice and applicable rules determine the available route and deadline.
Start my appeal→
See how it worksThe denial notice
Confirm the payer's stated reason, plan language, dates, and review rights from the actual notice.
Facts and evidence
Keep extracted information linked to its source. Unknown facts stay unknown until you or the clinician confirms them.
Route and review
Classify the next step, verify any deadline, and identify what requires treating-clinician review or signature.
Four clear stages.
Upload your denial — and any clinical records you have
Take a photo, scan, or upload PDFs of the denial letter. Adding labs, prior PA letters, or visit notes makes the appeal stronger — but the denial alone is enough to start.
Confirm a few facts
We pre-fill what was extracted. You confirm, correct, or leave it unknown.
We draft your appeal
A source-linked draft and evidence checklist for treating-clinician review.
Your doctor signs and files
We email the letter to you. Your doctor reviews, signs, and submits.
Common questions
Can I appeal a denied insurance claim for Lupus & rheumatology?
The denial notice and governing plan or program determine whether and how the decision can be challenged. DenialHelp first classifies the route, then organizes the relevant facts and sources. Filing dates vary and must be verified against the actual notice.
What does DenialHelp cost for a Lupus & rheumatology appeal?
$39 for a first-level appeal. Other review levels use the current prices shown on the pricing page. The refund promise concerns the described deliverable, not the insurer's decision.
Who reviews and signs the Lupus & rheumatology appeal letter?
The patient's treating physician reviews and signs the appeal letter before it is submitted to the insurer. DenialHelp drafts the letter; the patient and prescribing physician are responsible for submission. We do not file appeals on behalf of patients.
What treatments are covered under Lupus & rheumatology?
Benlysta (belimumab) IV 10 mg/kg q4wk or SC 200 mg weekly — FDA-approved Mar 2011 (SLE) and Dec 2020 (lupus nephritis), Saphnelo (anifrolumab-fnia) 300 mg IV q4wk — anti-IFN-α/β receptor, FDA-approved July/Aug 2021 for moderate-to-severe SLE, Lupkynis (voclosporin) 23.7 mg PO BID — calcineurin inhibitor, FDA-approved Jan 22, 2021 for active lupus nephritis, Hydroxychloroquine (Plaquenil) 5 mg/kg actual body weight/day — anchor antimalarial for all SLE, Mycophenolate mofetil (CellCept) 2-3 g/day or mycophenolic acid (Myfortic) — induction + maintenance for proliferative LN, Cyclophosphamide IV (low-dose Euro-Lupus 500 mg q2wk x 6 OR NIH high-dose 0.5-1 g/m² monthly) for severe LN or NPSLE, Rituximab (off-label) 1 g IV x 2 doses — for refractory SLE / LN despite negative LUNAR/EXPLORER pivotal trials, Azathioprine 2 mg/kg/day — maintenance immunosuppressive after induction
Ready to fight your denial?
Our free pre-payment review runs before checkout. Refund requests made within 7 calendar days of payment are processed automatically; later requests are reviewed under the Terms. A refund policy is not a promise of a payer outcome.
Start my appeal→